What is LGMK's health score?

LogicMark, Inc. (LGMK) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LGMK's estimated fair value?

Based on our 5-year discounted cash flow model, LogicMark, Inc.'s estimated fair value is $38.22 per share, representing a 3539.7% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LGMK undervalued or overvalued?

Our model currently rates LGMK as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LGMK... Refresh in a moment for the full analysis.

LogicMark, Inc. (LGMK)

Healthcare Undervalued low mixed

$1.05

Updated: 2026-06-06

TradeApes Score

Financial Strength

35 Weak

Operating Trend

60 Healthy

Relative Value

60 Healthy

Capital Allocation

40 Weak

Risk

50 Mixed

Est. Fair Value $38.22

DCF Upside +3539.7%

Sector Rank #2807 of 6982

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.